ORGANIZATION

Generic Use Rate at 73.2% in July-September: JGA

December 27, 2018
The generic utilization rate in Japan in July-September stood at a preliminary 73.2% on a volume basis, up 1 point over the previous quarter, the Japan Generic Medicines Association (JGA) data showed on December 26.The generic rate basically represents the…

To read the full story

ORGANIZATION

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…